SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Robert K. who wrote (6697)7/16/1998 10:34:00 AM
From: Robert K.  Respond to of 17367
 
Xoma 47 bpi patents, 20 more pending. All others worldwide ZERO.
Total patent lock IMO.
>>>>>>>>>>>>>>Great job xoma.>>>>>>>>>>>>.
Lets make a deal.
All disclaimers always apply.



To: Robert K. who wrote (6697)7/16/1998 12:55:00 PM
From: Robert S.  Read Replies (2) | Respond to of 17367
 
Upon hearing the Incyte license deal, I expected a greater reaction from the Street than thus far exhibited. A question pertaining to today's news is why did Incyte agree to this arrangement for such an insignificant sum? The prognostications presented here and elsewhere indicated that the potential market for BPI is large, yet, Incyte does not seem to share this view.